Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Baradaran

Showing results (201-210 of 725) with videos related to

Pageof 73
Sort By:
Cancer Cell International|November 8, 2023
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapyNajibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, et al.
Life Sciences|December 28, 2020
MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1Shirin Azarbarzin, Mohammad Ali Hosseinpour-Feizi, Seyed Mahdi Banan Khojasteh, et al.
EXCLI Journal|October 30, 2020
In vitro anticancer activity of <i>Scrophularia amplexicaulis</i> extracts on MCF-7 and WEHI-164 cell lineSamira Valiyari, Elham Beiranvand, Azin Samimi, et al.
Molecular Biology Reports|June 18, 2022
MicroRNA-143 act as a tumor suppressor microRNA in human lung cancer cells by inhibiting cell proliferation, invasion, and migrationVahid Asghariazar, Behzad Mansoori, Mahtab Kadkhodayi, et al.
Inflammopharmacology|June 14, 2021
Cholinergic anti-inflammatory pathway and connective tissue diseasesKhalil Hajiasgharzadeh, Alireza Khabbazi, Ahad Mokhtarzadeh, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 17, 2017
HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell linesNavideh Haghnavaz, Faezeh Asghari, Daniel Elieh Ali Komi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2015
Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60)Saeed Kachalaki, Behzad Baradaran, Jafar Majidi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2018
MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell lineNavaz Sadeghiyeh, Nasser Sehati, Behzad Mansoori, et al.
Advanced Pharmaceutical Bulletin|March 16, 2026
Mebendazole-Treated Human Monocyte-Derived Dendritic Cells Represent Promoted Immunogenic Phenotype with Augmented Expression of Inflammatory MarkersShiva Alipour, Sepideh Sohrabi, Amirhossein Mardi, et al.
Journal of Cellular Physiology|April 6, 2019
The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapyMohsen Alizadeh, Ali Safarzadeh, Fatemeh Beyranvand, et al.
Pageof 73

Showing results (201-210 of 725) with videos related to

Sort By:
Pageof 73
Cancer Cell International|November 8, 2023
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapyNajibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, et al.
Life Sciences|December 28, 2020
MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1Shirin Azarbarzin, Mohammad Ali Hosseinpour-Feizi, Seyed Mahdi Banan Khojasteh, et al.
EXCLI Journal|October 30, 2020
In vitro anticancer activity of <i>Scrophularia amplexicaulis</i> extracts on MCF-7 and WEHI-164 cell lineSamira Valiyari, Elham Beiranvand, Azin Samimi, et al.
Molecular Biology Reports|June 18, 2022
MicroRNA-143 act as a tumor suppressor microRNA in human lung cancer cells by inhibiting cell proliferation, invasion, and migrationVahid Asghariazar, Behzad Mansoori, Mahtab Kadkhodayi, et al.
Inflammopharmacology|June 14, 2021
Cholinergic anti-inflammatory pathway and connective tissue diseasesKhalil Hajiasgharzadeh, Alireza Khabbazi, Ahad Mokhtarzadeh, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 17, 2017
HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell linesNavideh Haghnavaz, Faezeh Asghari, Daniel Elieh Ali Komi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2015
Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60)Saeed Kachalaki, Behzad Baradaran, Jafar Majidi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2018
MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell lineNavaz Sadeghiyeh, Nasser Sehati, Behzad Mansoori, et al.
Advanced Pharmaceutical Bulletin|March 16, 2026
Mebendazole-Treated Human Monocyte-Derived Dendritic Cells Represent Promoted Immunogenic Phenotype with Augmented Expression of Inflammatory MarkersShiva Alipour, Sepideh Sohrabi, Amirhossein Mardi, et al.
Journal of Cellular Physiology|April 6, 2019
The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapyMohsen Alizadeh, Ali Safarzadeh, Fatemeh Beyranvand, et al.
Pageof 73